We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Events

09 Apr 2024 - 12 Apr 2024
15 Apr 2024 - 17 Apr 2024
23 Apr 2024 - 26 Apr 2024

Gastroenterologists View Tissue In Situ Using Confocal Laser Endomicroscope

By LabMedica International staff writers
Posted on 15 Dec 2011
Print article
The confocal laser endomicroscope allows physicians to examine a patient’s GI tissue at the cellular level in its natural environment. This results in fewer biopsies being sent to pathology labs.

The microscope is called Cellvizio and is manufactured by Mauna Kea Technologies (MKEA; Newtown, PA, USA), a French company with offices in the United States. Cellvizio is a miniature microscope that, once inserted into the GI tract, enables the physician to select cells for microscopic examination in order to make a more immediate decision regarding a diagnosis, as well as treatment.

The Cellvizio system was cleared by the Food and Drug Administration (FDA) and has received CE mark in Europe. The company’s second-generation system, the Cellvizio 100 series was cleared in Europe and the United States in 2011. Although this micro-miniature microscope allows gastroenterologists to evaluate individual cells and identify abnormal or malignant tissue, there will still be a need to collect a tissue biopsy for analysis of its DNA, RNA, and/or proteins. The complexity of those genetic tests and molecular diagnostics assays means that most of these tissue referrals will continue to be sent to pathologists.

One contributing technology that went into this micro-miniature microscope is a high-density chip capable of performing several functions within a tiny module. Essentially, the Cellivizio system is a focal probe threaded through a traditional endoscope.

Dangerous tissue can be identified during the initial diagnostic exam. This allows gastroenterologists to remove this tissue the same day, and then go back to ensure that all of the diseased tissue was removed. This new approach will be applied to gastrointestinal cancers and other GI diseases, including those of the colon, bile duct, pancreas, and esophagus.

The Cellvizo system has the potential to pull more testing away from the traditional anatomic pathology laboratory. Michael J. Cima, PhD, at the Massachusetts Institute of Technology (MIT; Cambridge, MA, USA), recognized that possibility when he stated that, by using these types of systems to look at tissue in situ, “we are going to bring the laboratory into the patient.”

Related Links:
Mauna Kea Technologies
Massachusetts Institute of Technology

Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Specimen Collection & Transport
POCT Fluorescent Immunoassay Analyzer
FIA Go
Gold Member
Xylazine Immunoassay Test
Xylazine ELISA

Print article

Channels

Clinical Chemistry

view channel
Image: Reaching speeds up to 6,000 RPM, this centrifuge forms the basis for a new type of inexpensive, POC biomedical test (Photo courtesy of Duke University)

POC Biomedical Test Spins Water Droplet Using Sound Waves for Cancer Detection

Exosomes, tiny cellular bioparticles carrying a specific set of proteins, lipids, and genetic materials, play a crucial role in cell communication and hold promise for non-invasive diagnostics.... Read more

Molecular Diagnostics

view channel
Image: MOF materials efficiently enrich cfDNA and cfRNA in blood through simple operational process (Photo courtesy of Science China Press)

Blood Circulating Nucleic Acid Enrichment Technique Enables Non-Invasive Liver Cancer Diagnosis

The ability to diagnose diseases early can significantly enhance the effectiveness of clinical treatments and improve survival rates. One promising approach for non-invasive early diagnosis is the use... Read more

Hematology

view channel
Image: The low-cost portable device rapidly identifies chemotherapy patients at risk of sepsis (Photo courtesy of 52North Health)

POC Finger-Prick Blood Test Determines Risk of Neutropenic Sepsis in Patients Undergoing Chemotherapy

Neutropenia, a decrease in neutrophils (a type of white blood cell crucial for fighting infections), is a frequent side effect of certain cancer treatments. This condition elevates the risk of infections,... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.